Welcome to this week's Chutes and Ladders, our roundup of hirings and retirings throughout the industry. Please send the good word--or the bad--from your shop to Eric Sagonowsky (email) or Amirah Al Idrus (email | Twitter), and we will feature it here at the end of each week.
Habib Dable to lead Bayer's U.S. pharma business |
|||||||||||||||||||
Bayer has a new U.S. pharmaceuticals leader in Habib Dable, who has been with the company since joining in 1994 as a sales representative. Previously, Dable was the global head of specialty medicine for Bayer HealthCare Pharmaceuticals, a role he held since 2013, managing the therapeutic areas of hematology, oncology, ophthalmology and neurology. In his new position, he'll report to Philip Blake, who moves to the role of head of the Americas for Bayer HealthCare Pharmaceuticals. "Habib Dable is a highly respected leader at Bayer, and I'm thrilled to have someone with such a wealth of experience step in to lead the company's largest pharmaceuticals market worldwide," Blake said in a statement. "Having spent more than two decades at Bayer in a range of key roles with increasing management responsibility, Habib will be a critical asset as we look to build on our positive momentum in the U.S. to create long-term growth." Release
|